LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Test Uses Glow-in-the-Dark Paper

By LabMedica International staff writers
Posted on 16 Oct 2018
Image: This close-up of the glow-in-the-dark paper strip contains two copies of the test. The three glowing dots per test indicate that you can check on three different antibodies within one test (Photo courtesy of Bart van Overbeeke).
Image: This close-up of the glow-in-the-dark paper strip contains two copies of the test. The three glowing dots per test indicate that you can check on three different antibodies within one test (Photo courtesy of Bart van Overbeeke).
A practicable and reliable way to test for infectious diseases has been found and all that is needed are a special glowing paper strip, a drop of blood and a digital camera.

The test uses fully integrated “sample‐in‐signal‐out” microfluidic paper‐based analytical devices (μPADs) relying on bioluminescence resonance energy transfer (BRET) switches for analyte recognition and colorimetric signal generation.

Scientists from the Eindhoven University of Technology (Eindhoven, the Netherlands) and their colleagues at the Keio University (Kohoku-ku, Japan) developed the devices use BRET‐based antibody sensing proteins integrated into vertically assembled layers of functionalized paper, and their design enables sample volume‐independent and fully reagent‐free operation, including on‐device blood plasma separation. User operation is limited to the application of a single drop (20–30 μL) of sample (serum, whole blood) and the acquisition of a photograph 20 minutes after sample introduction, with no requirement for precise pipetting, liquid handling, or analytical equipment except for a camera.

The color is created thanks to the secret ingredient of the paper strip: a so-called luminous sensor protein. After a droplet of blood comes onto the paper, this protein triggers a reaction in which blue light is produced (known as bioluminescence). An enzyme that also illuminates fireflies and certain fish, for example, plays a role in this. In a second step, the blue light is converted into green light, but here comes the clue: if an antibody binds to the sensor protein, it blocks the second step. A lot of green means few antibodies and, vice versa, less green means more antibodies.

The ratio of blue and green light can be used to derive the concentration of antibodies. By measuring the ratio precisely, they suffer less from problems that other biosensors often have, such as the signal becoming weaker over time. In their prototype, the team successfully tested three antibodies simultaneously, for human immunodeficiency virus (HIV), influenza and dengue fever. Maarten Merkx, PhD, a professor of Bioengineering and a leading author of the study, said, “A biochemical reaction causes the underside of paper to emit blue-green light; the bluer the color, the higher the concentration of antibodies. A digital camera, for example from a mobile phone, is sufficient to determine the exact color and thus the result.” The study was published on August 31, 2018, in the journal Angewandte Chemie International Edition.

Related Links:
Eindhoven University of Technology
Keio University

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more